thyroxine has been researched along with Breast Neoplasms in 114 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Various plasma hormones were measured in 13 pre- and 20 post-menopausal women with advanced breast cancer before and for 12 months after ovarian irradiation or during continuous administration of tamoxifen at a dose of 10 mg twice a day, respectively; some patients received additional prednisolone at a dose of 5 mg twice a day." | 9.05 | Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer. ( Blackburn, AM; Bulbrook, RD; Hoare, SA; Kwa, HG; Rubens, RD; Thomas, BS; Wang, DY, 1984) |
| "To investigate whether the use of levothyroxine was associated with breast cancer risk." | 7.88 | Levothyroxine use and the risk of breast cancer: a nation-wide population-based case-control study. ( Cheng, YT; Iqbal, U; Islam, MM; Jian, WS; Khan, HAA; Li, YC; Nguyen, PA; Poly, TN; Wang, YC; Wu, CC; Yang, HC; Yu, YY, 2018) |
| "L-Thyroxine is one of the most commonly prescribed drugs and accordingly used by many breast cancer patients with thyroid disorders." | 7.88 | L-Thyroxine intake as a potential risk factor for the development of fatigue in breast cancer patients undergoing chemotherapy. ( Habermann, N; Johnson, T; Schmidt, ME; Schneeweiss, A; Steindorf, K; Wiskemann, J, 2018) |
| "The aim was to evaluate tetraiodothyroacetic acid (tetrac), a thyroid hormone analog of L-thyroxin, conjugated to poly(lactic-co-glycolic acid) nanoparticles (T-PLGA-NPs) both in vitro and in vivo for the treatment of drug-resistant breast cancer." | 7.79 | Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer. ( Bharali, DJ; Davis, PJ; Mousa, SA; Yalcin, M, 2013) |
| "Thyroid function was evaluation in 26 postmenopausal women with breast cancer before and at various time intervals during treatment with tamoxifen." | 7.70 | Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. ( Aakvaag, A; Anker, GB; Lien, EA; Lønning, PE, 1998) |
| "Within a case-control study of postmenopausal breast cancer patients (n = 99) and matched healthy controls (n = 105), thyroid hormone levels were compared and correlated with toenail selenium concentrations." | 7.69 | Thyroid hormones and selenium status in breast cancer. ( Bokje, E; Coulter, J; Logan, H; Odling-Smee, W; Spence, RA; Steele, K; Stewart, C; Strain, JJ; van't Veer, P, 1997) |
| "Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 7.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
| "5 mg 1-alpha-methyl-dopahydrazine, 125 mg levodopa) were administered orally to 29 patients with tumours of the breast (16 with breast cancer, 13 with benign breast disease)." | 7.66 | The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours. ( Jenner, PG; Jones, MK; Ramsay, ID, 1978) |
| "Plasma triiodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) were measured in 44 early breast cancer patients, 48 with advanced breast cancer, 20 with cancer of the colon, and 56 healthy women of similar age." | 7.66 | Plasma triiodothyronine concentrations in breast cancer. ( Davis, TE; Rose, DP, 1979) |
| "Plasma TSH and thyroxine levels were measured in 74 early breast cancer patients and 53 with advanced disease, 77 patients with cancer arising in other organs and 67 healthy women of similar age." | 7.66 | Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer. ( Davis, TE; Rose, DP, 1978) |
| "The conflict between breast cancer (BC) and thyroid hormone (TH) has been studied for years." | 6.82 | Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysis. ( Deng, Q; Guo, D; Lei, Z; Wu, L; Zeng, B, 2022) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 6.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "Post-partum hair loss is possibly due to a reduction in the levels of oestradiol and thyroxine postnatally." | 5.31 | The relationship between thyroxine, oestradiol, and postnatal alopecia, with relevance to women's health in general. ( Pringle, T, 2000) |
| "Aminoglutethimide (Ag) has been used in different dosages with and without combined treatment with glucocorticoids for the suppression of peripheral plasma levels of steroidal hormones." | 5.27 | Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer. ( Alexieva-Figusch, J; de Jong, FH; Klign, JG; Lamberts, WJ; van Gilse, HA, 1987) |
| "The women with other-than-breast cancer and the women with miscellaneous non-cancerous illnesses also showed significant elevations of spot T4 levels, indistinguishable from those of the breast cancer patients." | 5.26 | Plasma levels of thyroxine and triiodothyronine in women with breast cancer. ( Fukushima, DK; Levin, J; Markham, M; O'Connor, J; Strain, GW; Zumoff, B, 1981) |
| "Various plasma hormones were measured in 13 pre- and 20 post-menopausal women with advanced breast cancer before and for 12 months after ovarian irradiation or during continuous administration of tamoxifen at a dose of 10 mg twice a day, respectively; some patients received additional prednisolone at a dose of 5 mg twice a day." | 5.05 | Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer. ( Blackburn, AM; Bulbrook, RD; Hoare, SA; Kwa, HG; Rubens, RD; Thomas, BS; Wang, DY, 1984) |
| "L-Thyroxine is one of the most commonly prescribed drugs and accordingly used by many breast cancer patients with thyroid disorders." | 3.88 | L-Thyroxine intake as a potential risk factor for the development of fatigue in breast cancer patients undergoing chemotherapy. ( Habermann, N; Johnson, T; Schmidt, ME; Schneeweiss, A; Steindorf, K; Wiskemann, J, 2018) |
| "To investigate whether the use of levothyroxine was associated with breast cancer risk." | 3.88 | Levothyroxine use and the risk of breast cancer: a nation-wide population-based case-control study. ( Cheng, YT; Iqbal, U; Islam, MM; Jian, WS; Khan, HAA; Li, YC; Nguyen, PA; Poly, TN; Wang, YC; Wu, CC; Yang, HC; Yu, YY, 2018) |
| "High fT4 was associated with a statistically significant higher risk of overall breast cancer, small, grade I, ER-positive, PgR-positive, and cyclin D1 low tumors." | 3.81 | Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study. ( Borgquist, S; Brandt, J; Manjer, J, 2015) |
| "The aim was to evaluate tetraiodothyroacetic acid (tetrac), a thyroid hormone analog of L-thyroxin, conjugated to poly(lactic-co-glycolic acid) nanoparticles (T-PLGA-NPs) both in vitro and in vivo for the treatment of drug-resistant breast cancer." | 3.79 | Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer. ( Bharali, DJ; Davis, PJ; Mousa, SA; Yalcin, M, 2013) |
| " Breast cancer cells were treated with Retinoic acid (ATRA), Estradiol and Thyroxine individually and in combination followed by analysis of changes in NIS expression." | 3.77 | The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue. ( Curran, CE; Dwyer, RM; Hennessy, E; Kerin, MJ; Morris, JC; Newell, J; Ryan, J, 2011) |
| "In the present study, we analyze and characterize the levels of PCBs and OH-PCBs in serum and breast adipose tissue, and measure TH (total 3,5,5'-triiodothyronine (tT3) and total l-thyroxine (tT4)) levels in serum of Japanese women diagnosed with breast cancer (n = 51) to know how PCBs affect thyroid hormone homeostasis." | 3.76 | Determination and characterization of hydroxylated polychlorinated biphenyls (OH-PCBs) in serum and adipose tissue of Japanese women diagnosed with breast cancer. ( Akiba, S; Koga, M; Koriyama, C; Nomiyama, K; Shinohara, R; Yamamoto, M; Yonehara, T; Yonemura, S, 2010) |
| "Thyroid function was evaluation in 26 postmenopausal women with breast cancer before and at various time intervals during treatment with tamoxifen." | 3.70 | Thyroid function in postmenopausal breast cancer patients treated with tamoxifen. ( Aakvaag, A; Anker, GB; Lien, EA; Lønning, PE, 1998) |
| "Within a case-control study of postmenopausal breast cancer patients (n = 99) and matched healthy controls (n = 105), thyroid hormone levels were compared and correlated with toenail selenium concentrations." | 3.69 | Thyroid hormones and selenium status in breast cancer. ( Bokje, E; Coulter, J; Logan, H; Odling-Smee, W; Spence, RA; Steele, K; Stewart, C; Strain, JJ; van't Veer, P, 1997) |
| "Aminoglutethimide is effective in the treatment of breast cancer in postmenopausal patients as a result of its inhibition of aromatase." | 3.68 | Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion. ( Cantwell, BM; Dowsett, M; Harris, AL; Mehta, A, 1991) |
| "The influence of tamoxifen on plasma lipids and lipoproteins was monitored in 46 postmenopausal and 8 premenopausal women treated for advanced breast cancer up till 6 months." | 3.67 | Tamoxifen, serum lipoproteins and cardiovascular risk. ( Bonfrer, JM; Bruning, PF; de Jong-Bakker, M; Hart, AA; Linders, D; Nooyen, WJ; van Loon, J, 1988) |
| "Serum tri-iodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) concentrations were measured in 50 postmenopausal patients with breast cancer receiving tamoxifen therapy." | 3.67 | The effect of tamoxifen therapy on thyroid function tests. ( Beastall, GH; Gordon, D; McArdle, CS; Thomson, JA, 1986) |
| "Levels of circulating estrone (E1), estradiol (E2), androst-4-ene-3,17-dione (Adione), 3,5,3'-triiodothyronine (T3), thyroxine (T4), and sex hormone-binding globulin (SHBG) were measured in 10 obese postmenopausal patients with breast cancer and in 10 obese postmenopausal control subjects matched for age, body size, and menopausal status." | 3.67 | Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss. ( Cardillo, LR; del Carmen Cremona, M; Enriori, CL; Etkin, AE; Orsini, W; Reforzo-Membrives, J, 1986) |
| "Plasma TSH and thyroxine levels were measured in 74 early breast cancer patients and 53 with advanced disease, 77 patients with cancer arising in other organs and 67 healthy women of similar age." | 3.66 | Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer. ( Davis, TE; Rose, DP, 1978) |
| "Plasma triiodothyronine (T3), thyroxine (T4) and thyroid-stimulating hormone (TSH) were measured in 44 early breast cancer patients, 48 with advanced breast cancer, 20 with cancer of the colon, and 56 healthy women of similar age." | 3.66 | Plasma triiodothyronine concentrations in breast cancer. ( Davis, TE; Rose, DP, 1979) |
| "In 41 women newly diagnosed as having breast cancer the thyroid function was assessed by determination of the serum TSH, tririodothyronine (T3), reverse triiodothyronine (rT3), thyroxine (T4), T3-resin uptake and free T4-index." | 3.66 | Thyroid function in breast cancer patients before and up to two years after mastectomy. ( Adami, HO; Hansen, J; Rimsten, A; Wide, L, 1979) |
| "5 mg 1-alpha-methyl-dopahydrazine, 125 mg levodopa) were administered orally to 29 patients with tumours of the breast (16 with breast cancer, 13 with benign breast disease)." | 3.66 | The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours. ( Jenner, PG; Jones, MK; Ramsay, ID, 1978) |
| "Serum 'free thyroxine' was measured as a thyroid function index (TFI) in 238 women with early breast cancer and 107 normal controls." | 3.66 | Thyroid function in early breast cancer. ( Bulbrook, RD; Hayward, JL; Millis, R; Russell, MJ; Thomas, BS, 1983) |
| "Patients with breast cancer were studied with regard to changes in the levels of serum thyroxine (T4) and serum triidothyronine (T3) after intramuscular administration of TSH for three days to investigate the thyroid reserve in these patients." | 3.65 | The thyroid reserve in patients with breast cancer. ( Abe, R; Kimura, M; Saito, S; Sakurada, T; Yoshida, K, 1977) |
| "The conflict between breast cancer (BC) and thyroid hormone (TH) has been studied for years." | 2.82 | Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysis. ( Deng, Q; Guo, D; Lei, Z; Wu, L; Zeng, B, 2022) |
| "An association between breast cancer and thyroid (autoimmune) diseases or the presence of thyroid peroxidase antibodies (TPOAb; a marker of thyroid autoimmune disease) has been suggested." | 2.71 | Hypothyroidism might be related to breast cancer in post-menopausal women. ( Coebergh, JW; Kuijpens, JL; Louwman, MW; Nyklíctek, I; Pop, VJ; Weetman, TA, 2005) |
| " While this regimen effectively blocked adrenal function, it was complicated by a drug interaction in which aminoglutethimide accelerated the metabolism and reduced the bioavailability of dexamethasone." | 2.36 | Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer. ( Harvey, H; Kendall, J; Lipton, A; Ruby, EB; Samojlik, E; Santen, RJ; Wells, SA, 1977) |
| "Genotyping was performed on 901 breast cancer patients and 3335 controls." | 1.48 | Thyroid-associated genetic polymorphisms in relation to breast cancer risk in the Malmö Diet and Cancer Study. ( Almgren, P; Borgquist, S; Brandt, J; Försti, A; Huss, L; Manjer, J; Melander, O, 2018) |
| "Metastasis is one of the major obstacles for successful therapy of breast tumor." | 1.48 | Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles. ( Hong, Y; Hu, F; Huang, X; Liu, X; Meng, T; Tan, Y; Yang, X; Yuan, H; Zhao, Y; Zhu, Y, 2018) |
| "Some 766 patients with incident breast cancer were identified, of whom 551 were eligible for analysis." | 1.43 | Thyroid function and survival following breast cancer. ( Almquist, M; Borgquist, S; Brandt, J; Manjer, J, 2016) |
| "Since BRCA1 associated breast cancers are frequently classified as hormone receptor negative or even triple negative, the application of endocrine therapies is rather limited in these patients." | 1.42 | Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways. ( Angele, M; Ditsch, N; Gallwas, J; Heublein, S; Jeschke, U; Mayr, D; Meindl, A, 2015) |
| "For human breast cancer cells, modeling suggested a higher sensitivity (lower IC50) to the effect on success rate of replication than the effect on rate of growth, whereas the capacity (Imax) was larger for the effect on growth rate." | 1.37 | Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system. ( Brown, D; Davis, FB; Davis, PJ; Drusano, GL; Kulawy, R; Landersdorfer, CB; Lim, CU; Lin, C; Lin, HY; Lin, S; London, D; Louie, A; Meng, R; Mousa, SA; Queimado, L; Tang, HY; Van Scoy, B, 2011) |
| "Thyroid function tests prior to breast cancer surgery were normal." | 1.35 | Exemestane-induced subclinical hypothyroidism : a case report. ( Karefilakis, CM; Mazokopakis, EE; Milkas, AN; Starakis, IK; Tsartsalis, AN, 2008) |
| "To investigate the role of primary hypothyroidism (HYPT) on breast carcinogenesis, the authors evaluated 1) the association between HYPT and a diagnosis of invasive breast carcinoma and 2) the clinicopathologic characteristics of breast carcinoma in patients with HYPT." | 1.33 | Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. ( Bevers, T; Cristofanilli, M; Hortobagyi, GN; Hsu, L; Kau, SW; Krishnamurthy, S; Patangan, M; Strom, S; Theriault, RL; Yamamura, Y, 2005) |
| "Human breast cancer (MCF-7) cells were incubated with physiological concentrations of l-T(4) or 17beta-estradiol (E(2)) for 15 min to 24 h, and nuclear ERalpha and serine-118-phosphorylated ERalpha were identified by Western blotting." | 1.32 | Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor. ( Davis, FB; Davis, PJ; Lin, HY; Tang, HY; Zhang, S, 2004) |
| "Post-partum hair loss is possibly due to a reduction in the levels of oestradiol and thyroxine postnatally." | 1.31 | The relationship between thyroxine, oestradiol, and postnatal alopecia, with relevance to women's health in general. ( Pringle, T, 2000) |
| "Aminoglutethimide (Ag) has been used in different dosages with and without combined treatment with glucocorticoids for the suppression of peripheral plasma levels of steroidal hormones." | 1.27 | Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer. ( Alexieva-Figusch, J; de Jong, FH; Klign, JG; Lamberts, WJ; van Gilse, HA, 1987) |
| "Subclinical and clinical primary hypothyroidism was significantly more frequent in breast cancer patients who had previously received irradiation on supraclavicular lymph nodes comprising a minor part of the thyroid." | 1.27 | Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes. ( Bonfrèr, J; Bruning, P; Burgers, M; De Jong-Bakker, M; Nooyen, W, 1985) |
| "Eight women with breast cancer (3." | 1.27 | Thyroid function in women with breast cancer. ( Baugnet-Mahieu, L; Lemaire, M, 1986) |
| "These results indicate that breast cancer and thyroid disease are probably related, but not in a specific way, since benign mastopathy also seems to be associated with thyroid disturbances." | 1.27 | Thyroid disease in patients with benign and malignant mastopathy. ( Adamopoulos, DA; Georgiakodis, F; Kapolla, N; Michalakis, A; Papadiamantis, J; Vassilaros, S, 1986) |
| "The women with other-than-breast cancer and the women with miscellaneous non-cancerous illnesses also showed significant elevations of spot T4 levels, indistinguishable from those of the breast cancer patients." | 1.26 | Plasma levels of thyroxine and triiodothyronine in women with breast cancer. ( Fukushima, DK; Levin, J; Markham, M; O'Connor, J; Strain, GW; Zumoff, B, 1981) |
| "Plasma T3 levels were reduced in both breast cancer group, but were reduced only in colonic cancer patients with systemic metastases." | 1.26 | Plasma thyronine levels in carcinoma of the breast and colon. ( Davis, TE; Rose, DP, 1981) |
| " Overall, there were no grounds to suggest that the long-term use of thyroid supplements increases the risk of breast cancer." | 1.26 | Use of thyroid supplements in relation to the risk of breast cancer. ( Kaufman, DW; Knapp, RC; Leavitt, T; Miettinen, OS; Rosenberg, L; Rosenshein, NB; Schottenfeld, D; Shapiro, S; Slone, D; Stolley, PD; Watring, WG, 1980) |
| "It is concluded that patients with breast cancer show more evidence of hypothyroidism as time progresses." | 1.26 | Thyroid function in patients with breast cancer. ( Goldie, DJ; Perry, M; Self, M, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 58 (50.88) | 18.7374 |
| 1990's | 11 (9.65) | 18.2507 |
| 2000's | 11 (9.65) | 29.6817 |
| 2010's | 25 (21.93) | 24.3611 |
| 2020's | 9 (7.89) | 2.80 |
| Authors | Studies |
|---|---|
| Meirovitz, A | 1 |
| Nisman, B | 2 |
| Allweis, TM | 2 |
| Carmon, E | 2 |
| Kadouri, L | 2 |
| Maly, B | 2 |
| Maimon, O | 2 |
| Peretz, T | 2 |
| He, X | 1 |
| Zhong, M | 1 |
| Zhang, Q | 1 |
| Aierken, N | 1 |
| Cui, L | 1 |
| Xing, Z | 1 |
| Lei, K | 1 |
| Lei, Z | 1 |
| Zeng, B | 1 |
| Wu, L | 1 |
| Deng, Q | 1 |
| Guo, D | 1 |
| Kolla, JN | 1 |
| Waissengrin, B | 3 |
| Zahavi, T | 3 |
| Salmon-Divon, M | 3 |
| Goldberg, A | 3 |
| Wolf, I | 3 |
| Rubinek, T | 3 |
| Winkler, T | 3 |
| Farkash, O | 3 |
| Grinshpun, A | 3 |
| Zubkov, A | 3 |
| Khatib, M | 3 |
| Shachar, SS | 3 |
| Keren, N | 3 |
| Carmi-Levy, I | 3 |
| Ben-David, U | 3 |
| Sonnenblick, A | 3 |
| Hercbergs, A | 2 |
| Lin, HY | 6 |
| Mousa, SA | 6 |
| Davis, PJ | 7 |
| Planck, T | 1 |
| Hedberg, F | 1 |
| Calissendorff, J | 1 |
| Nilsson, A | 1 |
| Meierovich, A | 1 |
| Jha, CK | 1 |
| Mishra, A | 1 |
| Yadav, SB | 1 |
| Agarwal, G | 1 |
| Singh, S | 1 |
| Chand, G | 1 |
| Agarwal, A | 1 |
| Mishra, SK | 1 |
| Yamauchi, I | 1 |
| Sakane, Y | 1 |
| Fukuda, Y | 1 |
| Fujii, T | 1 |
| Taura, D | 1 |
| Hirata, M | 1 |
| Hirota, K | 1 |
| Ueda, Y | 1 |
| Kanai, Y | 1 |
| Yamashita, Y | 1 |
| Kondo, E | 1 |
| Sone, M | 1 |
| Yasoda, A | 1 |
| Inagaki, N | 1 |
| Brandt, J | 3 |
| Borgquist, S | 3 |
| Almgren, P | 1 |
| Försti, A | 1 |
| Huss, L | 1 |
| Melander, O | 1 |
| Manjer, J | 4 |
| Zhao, Y | 1 |
| Tan, Y | 1 |
| Meng, T | 1 |
| Liu, X | 1 |
| Zhu, Y | 1 |
| Hong, Y | 1 |
| Yang, X | 1 |
| Yuan, H | 1 |
| Huang, X | 1 |
| Hu, F | 1 |
| Leinung, M | 1 |
| Schmidt, ME | 1 |
| Wiskemann, J | 1 |
| Johnson, T | 1 |
| Habermann, N | 1 |
| Schneeweiss, A | 1 |
| Steindorf, K | 1 |
| Wu, CC | 1 |
| Yu, YY | 1 |
| Yang, HC | 1 |
| Nguyen, PA | 1 |
| Poly, TN | 1 |
| Islam, MM | 1 |
| Iqbal, U | 1 |
| Khan, HAA | 1 |
| Wang, YC | 1 |
| Cheng, YT | 1 |
| Li, YC | 1 |
| Jian, WS | 1 |
| Ortega-Olvera, C | 1 |
| Ulloa-Aguirre, A | 1 |
| Ángeles-Llerenas, A | 1 |
| Mainero-Ratchelous, FE | 1 |
| González-Acevedo, CE | 1 |
| Hernández-Blanco, ML | 1 |
| Ziv, E | 1 |
| Avilés-Santa, L | 1 |
| Pérez-Rodríguez, E | 1 |
| Torres-Mejía, G | 1 |
| Kim, EY | 1 |
| Chang, Y | 1 |
| Lee, KH | 1 |
| Yun, JS | 1 |
| Park, YL | 1 |
| Park, CH | 1 |
| Ahn, J | 1 |
| Shin, H | 1 |
| Ryu, S | 1 |
| Bharali, DJ | 2 |
| Yalcin, M | 2 |
| Baldini, M | 1 |
| Gambini, D | 1 |
| Airaghi, L | 1 |
| Tomirotti, M | 1 |
| Cappellini, MD | 1 |
| Witczak, JK | 1 |
| Davies, R | 1 |
| Okosieme, OE | 1 |
| Cornelli, U | 1 |
| Belcaro, G | 1 |
| Recchia, M | 1 |
| Finco, A | 1 |
| Shi, XZ | 1 |
| Jin, X | 1 |
| Xu, P | 1 |
| Shen, HM | 1 |
| de Groot, S | 1 |
| Janssen, LG | 1 |
| Charehbili, A | 1 |
| Dijkgraaf, EM | 1 |
| Smit, VT | 1 |
| Kessels, LW | 1 |
| van Bochove, A | 1 |
| van Laarhoven, HW | 1 |
| Meershoek-Klein Kranenbarg, E | 1 |
| van Leeuwen-Stok, AE | 1 |
| van de Velde, CJ | 1 |
| Putter, H | 1 |
| Nortier, JW | 1 |
| van der Hoeven, JJ | 1 |
| Pijl, H | 1 |
| Kroep, JR | 1 |
| Heublein, S | 1 |
| Mayr, D | 1 |
| Meindl, A | 1 |
| Angele, M | 1 |
| Gallwas, J | 1 |
| Jeschke, U | 1 |
| Ditsch, N | 1 |
| Khan, MA | 1 |
| Bhurani, D | 1 |
| Agarwal, NB | 1 |
| Almquist, M | 1 |
| Khan, SR | 1 |
| Chaker, L | 1 |
| Ruiter, R | 1 |
| Aerts, JG | 1 |
| Hofman, A | 1 |
| Dehghan, A | 1 |
| Franco, OH | 1 |
| Stricker, BH | 1 |
| Peeters, RP | 1 |
| Sudha, T | 1 |
| Darwish, NH | 1 |
| Debreli Coskun, M | 1 |
| Keating, KA | 1 |
| Sandhu, MK | 1 |
| Brezden-Masley, C | 1 |
| Lipscombe, LL | 1 |
| Zagorski, B | 1 |
| Booth, GL | 1 |
| Mazokopakis, EE | 1 |
| Karefilakis, CM | 1 |
| Tsartsalis, AN | 1 |
| Milkas, AN | 1 |
| Starakis, IK | 1 |
| Glinskii, AB | 1 |
| Glinsky, GV | 1 |
| Tang, HY | 3 |
| Sun, M | 1 |
| Davis, FB | 3 |
| Luidens, MK | 1 |
| Hercbergs, AH | 1 |
| Nomiyama, K | 1 |
| Yonehara, T | 1 |
| Yonemura, S | 1 |
| Yamamoto, M | 1 |
| Koriyama, C | 1 |
| Akiba, S | 1 |
| Shinohara, R | 1 |
| Koga, M | 1 |
| Makaridze, T | 1 |
| Mardaleishvili, K | 1 |
| Ryan, J | 1 |
| Curran, CE | 1 |
| Hennessy, E | 1 |
| Newell, J | 1 |
| Morris, JC | 1 |
| Kerin, MJ | 1 |
| Dwyer, RM | 1 |
| Landersdorfer, CB | 1 |
| London, D | 1 |
| Meng, R | 1 |
| Lim, CU | 1 |
| Lin, C | 1 |
| Lin, S | 1 |
| Brown, D | 1 |
| Van Scoy, B | 1 |
| Kulawy, R | 1 |
| Queimado, L | 1 |
| Drusano, GL | 1 |
| Louie, A | 1 |
| Tosovic, A | 1 |
| Becker, C | 1 |
| Bondeson, AG | 1 |
| Bondeson, L | 1 |
| Ericsson, UB | 1 |
| Malm, J | 1 |
| LOESER, AA | 2 |
| MOESCHLIN, S | 2 |
| THALMANN, A | 2 |
| GORDAN, GS | 2 |
| DOTEVALL, G | 1 |
| WESTLING, H | 1 |
| DARGENT, M | 1 |
| BERGER, M | 1 |
| LAHNECHE, B | 1 |
| LYONS, AR | 1 |
| EDELSTYN, GA | 1 |
| Kumar, N | 1 |
| Allen, KA | 1 |
| Riccardi, D | 1 |
| Bercu, BB | 1 |
| Cantor, A | 1 |
| Minton, S | 1 |
| Balducci, L | 1 |
| Jacobsen, PB | 1 |
| Zhang, S | 1 |
| Cristofanilli, M | 1 |
| Yamamura, Y | 1 |
| Kau, SW | 1 |
| Bevers, T | 1 |
| Strom, S | 1 |
| Patangan, M | 1 |
| Hsu, L | 1 |
| Krishnamurthy, S | 1 |
| Theriault, RL | 1 |
| Hortobagyi, GN | 1 |
| Kuijpens, JL | 1 |
| Nyklíctek, I | 1 |
| Louwman, MW | 1 |
| Weetman, TA | 1 |
| Pop, VJ | 1 |
| Coebergh, JW | 1 |
| Ferreira, E | 1 |
| da Silva, AE | 1 |
| Serakides, R | 1 |
| Gomes, MG | 1 |
| Cassali, GD | 1 |
| Lin, CS | 1 |
| Lin, SH | 1 |
| Chiang, YH | 1 |
| Sheu, LF | 1 |
| Chao, TY | 1 |
| Fiore, E | 1 |
| Giustarini, E | 1 |
| Mammoli, C | 1 |
| Fragomeni, F | 1 |
| Campani, D | 1 |
| Muller, I | 1 |
| Pinchera, A | 1 |
| Giani, C | 1 |
| Blackburn, AM | 1 |
| Wang, DY | 1 |
| Bulbrook, RD | 3 |
| Thomas, BS | 4 |
| Kwa, HG | 1 |
| Hoare, SA | 1 |
| Rubens, RD | 2 |
| Sidorenko, LN | 1 |
| Popova, SP | 1 |
| Borina, ZN | 1 |
| Egor'kova, AS | 1 |
| Korovin, KF | 1 |
| Imayoshi, E | 1 |
| Soga, H | 1 |
| Nomura, S | 1 |
| Komatsubara, S | 1 |
| Satoh, G | 1 |
| Teramoto, S | 1 |
| Fukuda, K | 1 |
| Takashima, S | 1 |
| Russell, MJ | 2 |
| Hayward, JL | 3 |
| Millis, R | 1 |
| Abe, R | 3 |
| Hirosaki, A | 1 |
| Kimura, M | 2 |
| Rose, DP | 3 |
| Davis, TE | 3 |
| Zumoff, B | 1 |
| O'Connor, J | 1 |
| Levin, J | 1 |
| Markham, M | 1 |
| Strain, GW | 1 |
| Fukushima, DK | 1 |
| MacFarlane, IA | 1 |
| Robinson, EL | 1 |
| Bush, H | 1 |
| Durning, P | 1 |
| Howat, JM | 1 |
| Beardwell, CG | 1 |
| Shalet, SM | 1 |
| Shapiro, S | 1 |
| Slone, D | 1 |
| Kaufman, DW | 1 |
| Rosenberg, L | 1 |
| Miettinen, OS | 1 |
| Stolley, PD | 1 |
| Knapp, RC | 1 |
| Leavitt, T | 1 |
| Watring, WG | 1 |
| Rosenshein, NB | 1 |
| Schottenfeld, D | 1 |
| Arafah, BM | 1 |
| Mamby, CC | 1 |
| Love, RR | 1 |
| Lee, KE | 1 |
| Mi, YY | 1 |
| Zhou, MZ | 1 |
| Xiu, X | 1 |
| Dryzhak, VI | 1 |
| Strain, JJ | 1 |
| Bokje, E | 1 |
| van't Veer, P | 1 |
| Coulter, J | 1 |
| Stewart, C | 1 |
| Logan, H | 1 |
| Odling-Smee, W | 1 |
| Spence, RA | 1 |
| Steele, K | 1 |
| Loureiro, MM | 1 |
| Leite, VH | 1 |
| Boavida, JM | 1 |
| Raposo, JF | 1 |
| Henriques, MM | 1 |
| Limbert, ES | 1 |
| Sobrinho, LG | 1 |
| Anker, GB | 1 |
| Lønning, PE | 1 |
| Aakvaag, A | 1 |
| Lien, EA | 1 |
| Smyth, PP | 1 |
| Shering, SG | 1 |
| Kilbane, MT | 1 |
| Murray, MJ | 1 |
| McDermott, EW | 1 |
| Smith, DF | 1 |
| O'Higgins, NJ | 1 |
| Pringle, T | 1 |
| Beex, LV | 1 |
| Ross, A | 2 |
| Smals, AG | 1 |
| Kloppenborg, PW | 1 |
| Aldinger, KA | 1 |
| Schultz, PN | 1 |
| Blumenschein, GR | 1 |
| Samaan, NA | 1 |
| Santen, RJ | 3 |
| Samojlik, E | 1 |
| Lipton, A | 2 |
| Harvey, H | 2 |
| Ruby, EB | 1 |
| Wells, SA | 3 |
| Kendall, J | 1 |
| Cohn, N | 1 |
| Demers, LM | 1 |
| Misbin, RI | 1 |
| Foltz, EL | 1 |
| Adami, HO | 3 |
| Hansen, J | 1 |
| Rimsten, A | 2 |
| Wide, L | 3 |
| Di Palma, M | 1 |
| Gentileschi, G | 1 |
| Villa, S | 1 |
| Saito, S | 1 |
| Sakurada, T | 1 |
| Yoshida, K | 1 |
| Johansson, H | 1 |
| Thorén, L | 2 |
| Akerström, G | 1 |
| Beex, L | 1 |
| Smals, A | 1 |
| Kloppenborg, P | 1 |
| Haagensen, DE | 1 |
| Ruby, EJ | 1 |
| Dilley, WG | 1 |
| Jones, MK | 1 |
| Ramsay, ID | 1 |
| Jenner, PG | 1 |
| Vegelius, J | 1 |
| Perry, M | 1 |
| Goldie, DJ | 1 |
| Self, M | 1 |
| VanderLaan, WP | 1 |
| Larson, BA | 1 |
| Nagel-Studer, E | 1 |
| Staub, JJ | 1 |
| Nagel, GA | 1 |
| Malarkey, WB | 1 |
| Schroeder, LL | 1 |
| Stevens, VC | 1 |
| James, AG | 1 |
| Lanese, RR | 1 |
| Meier, P | 1 |
| Taneichi, Y | 1 |
| Kumagaya, N | 1 |
| Terui, K | 1 |
| Leese, GP | 1 |
| Jung, RT | 1 |
| Guthrie, C | 1 |
| Waugh, N | 1 |
| Browning, MC | 1 |
| Dowsett, M | 1 |
| Mehta, A | 1 |
| Cantwell, BM | 1 |
| Harris, AL | 1 |
| Ramaker, J | 1 |
| Wood, WG | 1 |
| Takatani, O | 2 |
| Okumoto, T | 1 |
| Kosano, H | 1 |
| Nishida, M | 1 |
| Hiraide, H | 1 |
| Tamakuma, S | 1 |
| de Launoit, Y | 1 |
| Kiss, R | 1 |
| Fentiman, IS | 1 |
| Balkwill, FR | 1 |
| Alexieva-Figusch, J | 1 |
| de Jong, FH | 1 |
| Lamberts, WJ | 1 |
| van Gilse, HA | 1 |
| Klign, JG | 1 |
| Bruning, PF | 1 |
| Bonfrer, JM | 1 |
| Hart, AA | 1 |
| de Jong-Bakker, M | 2 |
| Linders, D | 1 |
| van Loon, J | 1 |
| Nooyen, WJ | 1 |
| Bratusch-Marrain, P | 1 |
| Gries, FA | 1 |
| Komjati, M | 1 |
| Waldhäusl, W | 1 |
| Lemaire, M | 1 |
| Baugnet-Mahieu, L | 1 |
| Gordon, D | 1 |
| Beastall, GH | 1 |
| McArdle, CS | 1 |
| Thomson, JA | 1 |
| Goodman, MJ | 1 |
| Quinlan, M | 1 |
| Adamopoulos, DA | 1 |
| Vassilaros, S | 1 |
| Kapolla, N | 1 |
| Papadiamantis, J | 1 |
| Georgiakodis, F | 1 |
| Michalakis, A | 1 |
| Enriori, CL | 1 |
| Orsini, W | 1 |
| del Carmen Cremona, M | 1 |
| Etkin, AE | 1 |
| Cardillo, LR | 1 |
| Reforzo-Membrives, J | 1 |
| Bruning, P | 1 |
| Bonfrèr, J | 1 |
| Nooyen, W | 1 |
| Burgers, M | 1 |
| Lister, RC | 1 |
| Underwood, LE | 1 |
| Marshall, RN | 1 |
| Friesen, HG | 1 |
| Van Wyk, JJ | 1 |
| Saliamon, LS | 1 |
| Sadoff, L | 1 |
| Lusk, W | 1 |
| Pérez-Vega, E | 1 |
| Aguilar-Parada, E | 1 |
| Kato-Kato, A | 1 |
| Ibarra, A | 1 |
| Hutton, I | 1 |
| O'Bryan, RM | 1 |
| Kelley, RM | 1 |
| Ravdin, RG | 1 |
| Segaloff, A | 1 |
| Taylor, SG | 1 |
| Edelstyn, G | 1 |
| Gleadhill, C | 1 |
| Lyons, A | 1 |
| Hays, MT | 1 |
| da Silveira, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Progressive Resistance Training vs. Relaxation for Breast Cancer Patients During Chemotherapy: A Randomized Controlled Intervention Trial to Evaluate the Biological Mechanisms and Effects of Resistance Training on Fatigue and Quality of Life[NCT01106820] | 101 participants (Actual) | Interventional | 2010-04-30 | Completed | |||
| Study on the Compensatory Mechanism of Iodine Nutrition and the Optimal Intake Level of Lactating Women[NCT04492657] | 600 participants (Anticipated) | Observational | 2020-01-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for thyroxine and Breast Neoplasms
| Article | Year |
|---|---|
Free triiodothyronine and free thyroxine hormone levels in relation to breast cancer risk: a meta-analysis.
Topics: Breast Neoplasms; Female; Humans; Thyroid Hormones; Thyrotropin; Thyroxine; Triiodothyronine | 2022 |
(Thyroid) Hormonal regulation of breast cancer cells.
Topics: Breast Neoplasms; Estrogen Receptor alpha; Female; Humans; Thyroid Gland; Thyroid Hormones; Thyroxin | 2022 |
Thyroid Hormone in the Clinic and Breast Cancer.
Topics: Animals; Breast Neoplasms; Carcinogenesis; Hormone Replacement Therapy; Humans; Hypothyroidism; Thyr | 2018 |
Relationship between breast cancer and levels of serum thyroid hormones and antibodies: a meta-analysis.
Topics: Autoantibodies; Breast; Breast Neoplasms; Female; Humans; Iodide Peroxidase; Thyroglobulin; Thyroid | 2014 |
Kinetic, hormonal and clinical studies with aminoglutethimide in breast cancer.
Topics: Adrenocorticotropic Hormone; Aldosterone; Aminoglutethimide; Androstenedione; Breast Neoplasms; Dehy | 1977 |
6 trials available for thyroxine and Breast Neoplasms
| Article | Year |
|---|---|
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Fe | 2015 |
Hypothyroidism might be related to breast cancer in post-menopausal women.
Topics: Breast Neoplasms; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypothyroidism; Iodide Pe | 2005 |
Effect of prednisolone on hormone profiles during primary endocrine treatment of advanced breast cancer.
Topics: Breast Neoplasms; Clinical Trials as Topic; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; | 1984 |
Thyroid function test changes with adjuvant tamoxifen therapy in postmenopausal women with breast cancer.
Topics: Breast Neoplasms; Double-Blind Method; Female; Humans; Longitudinal Studies; Middle Aged; Postmenopa | 1995 |
Statistics and medical experimentation.
Topics: Aged; Bioethical Issues; Breast Neoplasms; Clinical Trials as Topic; Coronary Artery Bypass; Diabete | 1975 |
Primary hypothyroidism associated with interferon therapy of breast cancer.
Topics: Adult; Breast Neoplasms; Female; Humans; Hypothyroidism; Interferon Type I; Middle Aged; Thyroxine; | 1985 |
103 other studies available for thyroxine and Breast Neoplasms
| Article | Year |
|---|---|
Thyroid Hormones and Morphological Features of Primary Breast Cancer.
Topics: Adult; Aged; Biomarkers, Tumor; Breast Neoplasms; Carcinoma in Situ; Cell Proliferation; Female; Hum | 2022 |
Thyrotropin suppression therapy using levothyroxine does not negatively affect breast cancer prognosis.
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Neoplasms, Second Primary; Prognosis; SEER | 2022 |
Invited commentary on "Thyrotropin Suppression therapy Using Levothyroxine Does Not Negatively Affect Breast Cancer Prognosis".
Topics: Antineoplastic Agents; Breast Neoplasms; Female; Humans; Prognosis; Thyroid Neoplasms; Thyrotropin; | 2022 |
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Topics: Breast Neoplasms; Female; Genomics; Humans; Metformin; Neoplasm Recurrence, Local; Thyroxine | 2022 |
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Topics: Breast Neoplasms; Female; Genomics; Humans; Metformin; Neoplasm Recurrence, Local; Thyroxine | 2022 |
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Topics: Breast Neoplasms; Female; Genomics; Humans; Metformin; Neoplasm Recurrence, Local; Thyroxine | 2022 |
The effect of non-oncology drugs on clinical and genomic risk in early luminal breast cancer.
Topics: Breast Neoplasms; Female; Genomics; Humans; Metformin; Neoplasm Recurrence, Local; Thyroxine | 2022 |
Liothyronine Use in Hypothyroidism and its Effects on Cancer and Mortality.
Topics: Adult; Breast Neoplasms; Cause of Death; Drug Therapy, Combination; Female; Humans; Hypothyroidism; | 2021 |
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast Cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Disease-Free Survival; Female; | 2020 |
Thyroid dysfunctions and autoimmunity in breast cancer patients: a prospective case-control study.
Topics: Autoantibodies; Autoimmunity; Breast Neoplasms; Case-Control Studies; Female; Humans; Prospective St | 2021 |
Clinical Features of Nivolumab-Induced Thyroiditis: A Case Series Study.
Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Lung Neoplasm | 2017 |
Thyroid-associated genetic polymorphisms in relation to breast cancer risk in the Malmö Diet and Cancer Study.
Topics: Adult; Aged; Autoantibodies; Breast Neoplasms; Case-Control Studies; Female; Genetic Predisposition | 2018 |
Simultaneous targeting therapy for lung metastasis and breast tumor by blocking the NF-κB signaling pathway using Celastrol-loaded micelles.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Integrin alphaVb | 2018 |
L-Thyroxine intake as a potential risk factor for the development of fatigue in breast cancer patients undergoing chemotherapy.
Topics: Aged; Breast Neoplasms; Fatigue; Female; Humans; Middle Aged; Risk Factors; Thyroxine | 2018 |
Levothyroxine use and the risk of breast cancer: a nation-wide population-based case-control study.
Topics: Adult; Aged; Breast Neoplasms; Case-Control Studies; Female; Humans; Logistic Models; Middle Aged; O | 2018 |
Thyroid hormones and breast cancer association according to menopausal status and body mass index.
Topics: Adult; Body Mass Index; Breast Neoplasms; Case-Control Studies; Female; Humans; Incidence; Mexico; M | 2018 |
Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study.
Topics: Adult; Breast; Breast Neoplasms; Cohort Studies; Female; Humans; Metabolic Syndrome; Middle Aged; Pr | 2019 |
Tetraiodothyroacetic acid-conjugated PLGA nanoparticles: a nanomedicine approach to treat drug-resistant breast cancer.
Topics: Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxo | 2013 |
Remission of autoimmune hyperthyroidism after chemotherapy for cancer.
Topics: Adult; Antithyroid Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Comorbidity; Female; Graves | 2014 |
An unusual case of pituitary apoplexy.
Topics: Aged; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Hydrocortisone; Hypophysectomy; Hypopi | 2013 |
Levothyroxine and lung cancer in females: the importance of oxidative stress.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Commerce; Female; Gastrointestinal Neoplasms; Huma | 2013 |
Thyroid Hormone Receptors Predict Prognosis in BRCA1 Associated Breast Cancer in Opposing Ways.
Topics: Adult; BRCA1 Protein; Breast Neoplasms; Cell Line, Tumor; Cohort Studies; Female; Humans; Immunohist | 2015 |
Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to risk of different breast cancer subgroups: a Malmö Diet and Cancer Study.
Topics: Aged; Antibodies; Breast; Breast Neoplasms; Cyclin D1; Female; Humans; Iodide Peroxidase; Ki-67 Anti | 2015 |
Alteration of Thyroid Function in Indian HER 2-Negative Breast Cancer Patients Undergoing Chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Agents; Breast Neoplasms; Female; Humans; India; Middle Aged; Rece | 2015 |
Thyroid function and survival following breast cancer.
Topics: Aged; Antibodies; Breast Neoplasms; Female; Humans; Iodide Peroxidase; Middle Aged; Prospective Stud | 2016 |
Thyroid Function and Cancer Risk: The Rotterdam Study.
Topics: Aged; Breast Neoplasms; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Humans; Lung Neoplasm | 2016 |
Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug | 2017 |
Autoimmune hypothyroidism and breast cancer in the elderly.
Topics: Aged; Autoimmune Diseases; Breast Neoplasms; Canada; Cohort Studies; Female; Genes, BRCA1; Humans; H | 2009 |
Exemestane-induced subclinical hypothyroidism : a case report.
Topics: Aged; Androstadienes; Aromatase Inhibitors; Breast Neoplasms; Female; Follow-Up Studies; Humans; Hyp | 2008 |
Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).
Topics: Breast Neoplasms; Carrier Proteins; Caspase 2; Cell Line, Tumor; Cell Proliferation; Cysteine Endope | 2009 |
Determination and characterization of hydroxylated polychlorinated biphenyls (OH-PCBs) in serum and adipose tissue of Japanese women diagnosed with breast cancer.
Topics: Adipose Tissue; Breast Neoplasms; Female; Humans; Hydroxylation; Japan; Polychlorinated Biphenyls; T | 2010 |
Novelties in treatment approach of poly-neoplasias developed during thyroid pathologies.
Topics: Antidepressive Agents, Second-Generation; Breast Neoplasms; Dopamine; Female; Humans; Male; Mastecto | 2010 |
The sodium iodide symporter (NIS) and potential regulators in normal, benign and malignant human breast tissue.
Topics: Breast Neoplasms; Estradiol; Female; Fibroadenoma; Gene Expression Regulation, Neoplastic; Humans; M | 2011 |
Pharmacodynamic modeling of anti-cancer activity of tetraiodothyroacetic acid in a perfused cell culture system.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Apoptosis; Breast | 2011 |
Prospectively measured thyroid hormones and thyroid peroxidase antibodies in relation to breast cancer risk.
Topics: Autoantibodies; Breast Neoplasms; Cell Proliferation; Female; Humans; Iodide Peroxidase; Middle Aged | 2012 |
[Thyroid hormone as a prophylactic remedy in the metastasis of mammary and genital cancer in women].
Topics: Breast Neoplasms; Female; Genitalia; Genitalia, Female; Humans; Neoplasms; Thyroid Hormones; Thyroxi | 1955 |
[Results of combined prednisone (meticorten) and thyroxin therapy in severe cancer of breast].
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone; Thyroxine | 1956 |
[Results of combined prednisone (meticorten) and thyroxin therapy in severe cancer of breast].
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone; Thyroxine | 1956 |
[Results of combined prednisone (meticorten) and thyroxin therapy in severe cancer of breast].
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone; Thyroxine | 1956 |
[Results of combined prednisone (meticorten) and thyroxin therapy in severe cancer of breast].
Topics: Breast; Breast Neoplasms; Humans; Neoplasms; Prednisone; Thyroxine | 1956 |
A DIRECT ACTION OF PARATHYROID HORMONE ON DEAD BONE IN VITRO.
Topics: Adrenocorticotropic Hormone; Bone and Bones; Breast Neoplasms; Calcium; Calcium Isotopes; Calcium, D | 1963 |
GASTRIC ACID SECRETION BEFORE AND AFTER HYPOPHYSECTOMY IN MAN.
Topics: Breast Neoplasms; Cortisone; Diabetic Retinopathy; Gastric Acid; Gastric Juice; Histamine; Humans; H | 1963 |
[THYROID FUNCTION IN PATIENTS WITH CANCER OF THE BREAST].
Topics: Breast; Breast Neoplasms; Humans; Metabolism; Neoplasms; Pathology; Thyroid Function Tests; Thyroid | 1964 |
THYROID HORMONE AS A PROPHYLACTIC AGENT FOLLOWING RADICAL TREATMENT OF BREAST CANCER.
Topics: Breast Neoplasms; Drug Therapy; Humans; Mastectomy; Neoplasm Metastasis; Neoplasm Recurrence, Local; | 1965 |
The combined action of male and thyroid hormone on cancer of the female breast and genitalia; preliminary report.
Topics: Androgens; Breast; Breast Neoplasms; Genitalia; Genitalia, Female; Humans; Neoplasms; Thyroxine | 1952 |
Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?
Topics: Adult; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophos | 2004 |
Thyroid hormone causes mitogen-activated protein kinase-dependent phosphorylation of the nuclear estrogen receptor.
Topics: Breast Neoplasms; Cell Division; Cell Line, Tumor; Cell Nucleus; Enzyme Inhibitors; Estradiol; Estro | 2004 |
Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma.
Topics: Adult; Age Distribution; Aged; Breast Neoplasms; Case-Control Studies; Comorbidity; Female; Humans; | 2005 |
Ehrlich tumor as model to study artificial hyperthyroidism influence on breast cancer.
Topics: Animals; Antigens, Nuclear; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ehrlich Tumor; Cell Nucl | 2007 |
Diabetes insipidus revealing an isolated pituitary stalk metastasis of breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; | 2007 |
Favorable predictive value of thyroid autoimmunity in high aggressive breast cancer.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Autoimmunity; Breast Neoplasms; Carcinoma, Ductal; Disease | 2007 |
[Indices of thyroid activity in patients with breast cancer].
Topics: Adult; Breast Neoplasms; Female; Humans; Middle Aged; Thyroid Function Tests; Thyroid Gland; Thyrotr | 1984 |
[Hormonal profiles and structures in normal women and in patients with benign and malignant breast diseases].
Topics: 17-Ketosteroids; Adult; Breast Diseases; Breast Neoplasms; Estradiol; Female; Humans; Hydrocortisone | 1984 |
Thyroid function in early breast cancer.
Topics: Adult; Aged; Androsterone; Breast Neoplasms; Etiocholanolone; Female; Humans; Mastectomy; Middle Age | 1983 |
Pituitary-thyroid function in patients with breast cancer.
Topics: Breast Neoplasms; Female; Humans; Iodine Radioisotopes; Lymphatic Metastasis; Middle Aged; Pituitary | 1980 |
Plasma thyronine levels in carcinoma of the breast and colon.
Topics: Adult; Breast Neoplasms; Carcinoma; Colonic Neoplasms; Female; Humans; Liver Neoplasms; Middle Aged; | 1981 |
Plasma levels of thyroxine and triiodothyronine in women with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasms; Thyroxine; Triiodothyronine | 1981 |
Thyroid function in patients with benign and malignant breast disease.
Topics: Adolescent; Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Humans; Middle Aged; Thyroid Fun | 1980 |
Use of thyroid supplements in relation to the risk of breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Risk; Thyroxine | 1980 |
Decreased levothyroxine requirement in women with hypothyroidism during androgen therapy for breast cancer.
Topics: Aged; Breast Neoplasms; Female; Fluoxymesterone; Humans; Hypothyroidism; Middle Aged; Palliative Car | 1994 |
[Study of relationship between TCM syndrome-types of malignant tumours and thyroid functional test].
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Diagnosis, Differential; Digestive System Neoplasm | 1995 |
[Thyroid function in breast cancer patients].
Topics: Adult; Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Radioimmunoassay; Thyroid Gland; Th | 1993 |
Thyroid hormones and selenium status in breast cancer.
Topics: Aged; Breast Neoplasms; Case-Control Studies; Female; Humans; Iodide Peroxidase; Middle Aged; Nails; | 1997 |
An unusual case of papillary carcinoma of the thyroid with cutaneous and breast metastases only.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Middle | 1997 |
Thyroid function in postmenopausal breast cancer patients treated with tamoxifen.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Breast Neoplasms; Female; Humans; Middle Aged; Postme | 1998 |
Serum thyroid peroxidase autoantibodies, thyroid volume, and outcome in breast carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Autoantibodies; Breast Neoplasms; Female; Humans; Iodide Peroxidase; | 1998 |
The relationship between thyroxine, oestradiol, and postnatal alopecia, with relevance to women's health in general.
Topics: Alopecia; Breast Neoplasms; Estradiol; Female; Humans; Premenopause; Thyroxine | 2000 |
Letter: 5-fluorouracil and the thyroid.
Topics: Breast Neoplasms; Female; Fluorouracil; Humans; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyron | 1976 |
Thyroid-stimulating hormone and prolactin levels in breast cancer.
Topics: Adult; Breast Neoplasms; Female; Humans; Hypothalamo-Hypophyseal System; Middle Aged; Prolactin; Thy | 1978 |
Compensatory increase in TSH secretion without effect on prolactin secretion in patients treated with aminoglutethimide.
Topics: Adult; Aminoglutethimide; Breast Neoplasms; Chlorpromazine; Female; Follicle Stimulating Hormone; Hu | 1977 |
Plasma thyroid-stimulating hormone and thyroxine concentrations in breast cancer.
Topics: Aged; Breast Neoplasms; Female; Humans; Hypothyroidism; Middle Aged; Neoplasms; Thyrotropin; Thyrotr | 1978 |
Plasma triiodothyronine concentrations in breast cancer.
Topics: Adult; Age Factors; Aged; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Middle Aged; Thyroid | 1979 |
Thyroid function in breast cancer patients before and up to two years after mastectomy.
Topics: Adult; Aged; Breast Neoplasms; Female; Follow-Up Studies; Humans; Mastectomy; Middle Aged; Thyroid F | 1979 |
[Determination of serum iodoproteins in breast neoplasms].
Topics: Breast Neoplasms; Female; Humans; Iodoproteins; Neoplasm Metastasis; Thyrotropin; Thyroxine | 1979 |
The thyroid reserve in patients with breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Humans; Hypothyroidism; Middle Aged; Thyroiditis, Autoimmune; Thyroxi | 1977 |
Serum levels of TSH, T3, rT3, T4 and T3-resin uptake in surgical trauma.
Topics: Adult; Aged; Breast Neoplasms; Cholecystectomy; Female; Humans; Mastectomy; Middle Aged; Resins, Pla | 1978 |
5-fluorouracil-induced increase of total serum thyroxine and triiodothyronine.
Topics: Aged; Breast Neoplasms; Female; Fluorouracil; Humans; Middle Aged; Thyrotropin; Thyroxine; Triiodoth | 1977 |
Medical adrenalectomy with aminoglutethimide: clinical studies in postmenopausal patients with metastatic breast carcinoma.
Topics: Adrenal Cortex; Adrenalectomy; Aldosterone; Aminoglutethimide; Androstenedione; Bone Neoplasms; Brea | 1978 |
The effect of low dose carbidopa/levodopa on prolactin and growth hormone concentrations in patients with breast cancer and in benign breast tumours.
Topics: Adult; Aged; Breast Neoplasms; Carbidopa; Dihydroxyphenylalanine; Female; Growth Hormone; Humans; Hy | 1978 |
Thyroid disease and function in breast cancer patients and non-hospitalized controls evaluated by determination of TSH, T3, rT3 and T4 levels in serum.
Topics: Adult; Aged; Breast Neoplasms; Female; Humans; Middle Aged; Thyroid Diseases; Thyroid Gland; Thyrotr | 1978 |
Thyroid function in patients with breast cancer.
Topics: Breast Neoplasms; Female; Humans; Hypothyroidism; Thyroid Gland; Thyrotropin; Thyroxine | 1978 |
The thyroid, prolactin, and breast cancer.
Topics: Animals; Breast Neoplasms; Humans; Mice; Prolactin; Rats; Thyroid Gland; Thyrotropin; Thyroxine | 1978 |
[Biology of breast cancer: current approaches to new treatment modalities (conclusion)].
Topics: Breast Neoplasms; Estrogens; Female; Humans; Personality; Prolactin; Stress, Physiological; Thyroxin | 1978 |
Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease.
Topics: Adult; Breast Neoplasms; Circadian Rhythm; Estradiol; Female; Follicle Stimulating Hormone; Follicul | 1977 |
[Thyroid gland function on breast neoplasms].
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Female; Humans; Iodine Radioisotopes; Middle Aged; Radion | 1975 |
Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH.
Topics: Aged; Breast Neoplasms; Depression, Chemical; Female; Femoral Neck Fractures; Follow-Up Studies; Fra | 1992 |
Low-dose aminoglutethimide in postmenopausal breast cancer: effects on adrenal and thyroid hormone secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenocorticotropic Hormone; Aminoglutethimide; Androstenedione; Breas | 1991 |
Transthyretin--an explanation of "anomalous" serum thyroid hormone values in severe illness?
Topics: Adult; Aged; Breast Neoplasms; Female; Gastrointestinal Neoplasms; Humans; Hyperthyroidism; Hypothyr | 1990 |
Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women.
Topics: Adult; Breast Neoplasms; Estradiol; Female; Humans; Japan; Menopause; Middle Aged; Random Allocation | 1989 |
Influence of L-thyroxine, L-triiodothyronine, thyroid stimulating hormone, or estradiol on the cell kinetics of cultured mammary cancer cells.
Topics: Animals; Breast Neoplasms; Cell Cycle; Drug Interactions; Estradiol; Humans; Interphase; Kinetics; M | 1989 |
Endocrine effects of aminoglutethimide plus hydrocortisone versus effects of high dose of hydrocortisone alone in postmenopausal metastatic breast cancer.
Topics: Aged; Aminoglutethimide; Androstenedione; Antineoplastic Combined Chemotherapy Protocols; Breast Neo | 1987 |
Tamoxifen, serum lipoproteins and cardiovascular risk.
Topics: Adult; Aged; Breast Neoplasms; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, | 1988 |
[A 58-year-old type-II diabetic patient with severe insulin resistance].
Topics: Autoantibodies; Breast Neoplasms; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Insulin | 1987 |
Thyroid function in women with breast cancer.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Humans; Middle Aged; Neoplasms; Thyroid Glan | 1986 |
The effect of tamoxifen therapy on thyroid function tests.
Topics: Breast Neoplasms; Female; Humans; Menopause; Middle Aged; Tamoxifen; Thyroid Function Tests; Thyroid | 1986 |
Thyroid function and the incidence of breast cancer in Hawaiian, British and Japanese women.
Topics: Adult; Body Weight; Breast Neoplasms; Female; Hawaii; Humans; Japan; Middle Aged; Risk; Serum Albumi | 1986 |
Thyroid disease in patients with benign and malignant mastopathy.
Topics: Adult; Aged; Breast Diseases; Breast Neoplasms; Female; Fibrocystic Breast Disease; Humans; Middle A | 1986 |
Decrease of circulating level of SHBG in postmenopausal obese women as a risk factor in breast cancer: reversible effect of weight loss.
Topics: Aged; Androstenedione; Body Weight; Breast Neoplasms; Estradiol; Estrone; Female; Humans; Hydrocorti | 1986 |
Primary hypothyroidism in breast cancer patients with irradiated supraclavicular lymph nodes.
Topics: Aged; Autoantibodies; Breast Neoplasms; Female; Humans; Hypothyroidism; Lymph Nodes; Lymphatic Metas | 1985 |
Editorial: The thyroid, prolactin, and breast cancer.
Topics: Breast Neoplasms; Female; Humans; Hypothyroidism; Prolactin; Thyroid Gland; Thyrotropin; Thyroxine | 1974 |
Evidence for a direct effect of thyrotropin-releasing hormone (TRH) on prolactin release in humans.
Topics: Adrenal Insufficiency; Aged; Binding, Competitive; Breast Neoplasms; Chlorpromazine; Cortisone; Fema | 1974 |
[Analysis of tumor transformation of tissue. I. Indications of the degree of autonomy and their appearance].
Topics: Adenoma; Adenosine Triphosphate; Animals; Breast Neoplasms; Carcinogens; Carcinoma, Hepatocellular; | 1969 |
The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol T4 LH and testosterone in patients with advanced cancer.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Estrog | 1974 |
[Free urinary thyroxine].
Topics: Adult; Breast Neoplasms; Castration; Chromatography, Gel; Diethylstilbestrol; Evaluation Studies as | 1973 |
Double major ablation for mammary carcinoma.
Topics: Adult; Breast Neoplasms; Female; Humans; Hypophysectomy; Iodine Radioisotopes; Mastectomy; Neoplasm | 1973 |
Does thyroid substance improve response of breast cancer to surgical castration.
Topics: Breast Neoplasms; Castration; Evaluation Studies as Topic; Female; Humans; Neoplasm Metastasis; Ovar | 1974 |
Total hypophysectomy for advanced breast cancer.
Topics: Androgens; Blindness; Breast Neoplasms; Cortisone; Cyclophosphamide; Estrogens; Female; Humans; Hypo | 1968 |
Absorption of oral thyroxine in man.
Topics: Adult; Breast Neoplasms; Epinephrine; Female; Hepatitis; Humans; Hyperthyroidism; Intestinal Absorpt | 1968 |
[The thyroid hormone as complementary treatment in genital and mammary cancer].
Topics: Breast Neoplasms; Female; Genital Neoplasms, Female; Thyroxine | 1965 |